Cancer Immunology, Immunotherapy

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity

• Review

Cédric Ménard, François Martin, Lionel Apetoh, Florence Bouyer, François Ghiringhelli

Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration

• Open Access
• Original Article

A. C. Inge Boullart, Erik H. J. G. Aarntzen, Pauline Verdijk, Joannes F. M. Jacobs, Danita H. Schuurhuis, Daniel Benitez-Ribas, Gerty Schreibelt, Mandy W. M. M. van de Rakt, Nicole M. Scharenborg, Annemiek de Boer, Matthijs Kramer, Carl G. Figdor, Cornelis J. A. Punt, Gosse J. Adema, I. Jolanda M. de Vries

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

• Original Article

Jaafar Bennouna, Emmanuelle Bompas, Eve Marie Neidhardt, Frédéric Rolland, Irène Philip, Céline Galéa, Samuel Salot, Soraya Saiagh, Marie Audrain, Marie Rimbert, Sylvie Lafaye-de Micheaux, Jérôme Tiollier, Sylvie Négrier

Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP–PKA signaling and immunosuppression

• Original Article

Yunyun Su, Xiaojun Huang, Tatiana Raskovalova, Lefteris Zacharia, Anna Lokshin, Edwin Jackson, Elieser Gorelik

Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen

• Original Article

Michela Croce, Raffaella Meazza, Anna M. Orengo, Marina Fabbi, Martina Borghi, Domenico Ribatti, Beatrice Nico, Barbara Carlini, Vito Pistoia, Maria Valeria Corrias, Silvano Ferrini

Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer

• Original Article

Benjamin B. Williams, Meg Wall, Rebecca Yu Miao, Brenda Williams, Ivan Bertoncello, Michael H. Kershaw, Theo Mantamadiotis, Michelle Haber, Murray D. Norris, Anand Gautam, Phillip K. Darcy, Robert G. Ramsay

Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling

• Original Article

Hirobumi Asai, Hiroko Iijima, Kenichi Matsunaga, Yoshiharu Oguchi, Hidetoshi Katsuno, Koutaro Maeda

Combination of two fiber-mutant adenovirus vectors, one encoding the chemokine FKN and another encoding cytokine interleukin 12, elicits notably enhanced anti-tumor responses

• Original Article

Jian-Qing Gao, Naoko Kanagawa, Dong-Hang Xu, Min Han, Toshiki Sugita, Yutaka Hatanaka, Yoichi Tani, Hiroyuki Mizuguchi, Yasuo Tsutsumi, Tadanori Mayumi, Naoki Okada, Shinsaku Nakagawa

Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells

• Original Article

Patrizia Stoitzner, Laura K. Green, Jae Y. Jung, Kylie M. Price, Haley Atarea, Bronwyn Kivell, Franca Ronchese

Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells

• Erratum

Patrizia Stoitzner, Laura K. Green, Jae Y. Jung, Kylie M. Price, Haley T. Ataera, Bronwyn Kivell, Franca Ronchese

Progress in Vaccination against Cancer 2007 (PIVAC 7)

• Symposium Paper

A novel immunoregulatory axis of NKT cell subsets regulating tumor immunity

• Symposium Paper

Jay A. Berzofsky, Masaki Terabe

Oncoantigens as anti-tumor vaccination targets: the chance of a lucky strike?

• Symposium Paper

Raffaele Adolfo Calogero, Elena Quaglino, Silvia Saviozzi, Guido Forni, Federica Cavallo

Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumors

• Symposium Paper

Hyun-Il Cho, Guilian Niu, Norma Bradley, Esteban Celis

Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia

• Symposium Paper

M. Palma, L. Adamson, L. Hansson, P. Kokhaei, R. Rezvany, H. Mellstedt, A. Österborg, A. Choudhury

The “A, B and C” of Her-2 DNA vaccine development

• Symposium Paper

Wei-Zen Wei, Jennifer Jacob, Olga Radkevich-Brown, Paula Whittington, Yi-chi M. Kong

Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

• Symposium Paper

Barbara Seliger

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

• Symposium Paper

Natalia Aptsiauri, Rafael Carretero, Angel Garcia-Lora, Luis M. Real, Teresa Cabrera, Federico Garrido

Cancer treatment: the combination of vaccination with other therapies

• Open Access
• Symposium Paper

Mads Hald Andersen, Rikke Bæk Sørensen, David Schrama, Inge Marie Svane, Jürgen C. Becker, Per thor Straten